|
|
|
|
| Advertisement |
 |
|
| INTERVIEW |
 |
|
Unprecedented Times for Market Access |
Amy Mahery, recently appointed Global Head of Market Access and Pricing of the healthcare business of Merck KGaA, Darmstadt, Germany, discusses her key priorities and how she will draw on her multi-faceted industry experience to approach the challenges ahead
… /Read more/ |
|
|
|
|
|
|
|
/ March 8-11, 2020: Pharma Forum 2020
/ |
|
New York City, NY |
|
/ March 30–31, 2020: 6th Edition Drug Pricing Transparency Congress
/ |
|
Philadelphia, PA |
|
/ March 31–April 2, 2020: eyeforpharma Barcelona 2020
/ |
|
Barcelona, Spain |
|
/ April 20–22, 2020: Digital Health for Pharma
/ |
|
Philadelphia, PA. |
|
/ April 29–May 1, 2020: Pharmaceutical Compliance Congress (PCC) 2020
/ |
|
Washington, D.C. |
|
/ June 14–18, 2020: DIA 2020 Global Annual Meeting
/ |
|
Washington, D.C. |
 |
|
| |
|
|
|
|
|
|
|
|
| Advertisement |
|
| |
| Industry update |
| //Kathryn Metcalfe was appointed Bristol-Myers Squibb’s Executive Vice President of Corporate Affairs, effective 6 January 2020. Tim Power will take on the role of BMS’ Vice President and Head of Investor Relations upon the retirement of John Elicker in March 2020.
//
Former Celgene Chief Medical Officer Jay Backstrom has joined Acceleron Pharma in the newly created role of Head of Research and Development.
//
Cerecin (Singapore and Denver, CO), a biopharmaceutical company focused on brain health, announced that Joseph S. Zakrzewski has joined the company’s Board of Directors as Chairman.
|
|
|
|
|
|
|
|
|
Read More